0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Cell Therapy’s Next Chapter in the Advanced Therapy Medicinal Products CDMO MarketGene editing, CAR-T, and cell-based regenerative medicine are moving from the lab into commercial reality. Many developers cannot build the specialized manufacturing capacity these products need on their own, so they are turning to contract development and manufacturing organizations (CDMOs). According to Grand View Research, the global advanced therapy medicinal products CDMO market was valued...0 Comments 0 Shares 37 Views 0 Reviews
-
How Is Long-Term Ultra-Low Preservation Infrastructure Supporting Advanced Cell and Gene Therapy Storage?The growth of personalized cell therapies, specialized tissue engineering, and international bio-banking networks requires specialized cold storage systems capable of maintaining strict thermal control. Standard refrigeration equipment cannot protect fragile biological structures from structural crystallization and cellular degradation over extended periods. Cryogenic bio-freezers utilizing...0 Comments 0 Shares 275 Views 0 Reviews
-
How Is Long-Term Ultra-Low Preservation Infrastructure Supporting Advanced Cell and Gene Therapy Storage?The growth of personalized cell therapies, specialized tissue engineering, and international bio-banking networks requires specialized cold storage systems capable of maintaining strict thermal control. Standard refrigeration equipment cannot protect fragile biological structures from structural crystallization and cellular degradation over extended periods. Cryogenic bio-freezers utilizing...0 Comments 0 Shares 313 Views 0 Reviews
-
How Rising Hematological Malignancies and Advanced Therapy Investments Are Driving the Germany Car T Cell Therapy MarketThe Germany Car T Cell Therapy market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced cellular therapies to address the rising incidence of hematological malignancies and improve patient outcomes. The market was valued at USD 692.85 million in 2024 and is projected to reach USD 3,374.8 million by 2035, growing at a CAGR of 15.48%. The...0 Comments 0 Shares 376 Views 0 Reviews
-
Thymus (T)-Cell Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Thymus (T)-Cell Therapy Market CAGR ValueThe Thymus (T)-Cell Therapy Market was valued at USD 10.76 billion in 2025 and is projected to reach USD 41.97 billion by 2033, growing at a CAGR of 18.55% from 2026 to 2033. The market is witnessing strong growth driven by the rising global burden of cancer and...0 Comments 0 Shares 21 Views 0 Reviews